The Valley Desk

NCT03886701 · Interventional trial

Doravirine, Rifapentine and Isoniazid Interaction

Overall registry status Completed

Phase 1

Conditions Drug Interaction Potentiation, Human Immunodeficiency Virus, Latent Tuberculosis, Rifamycins Causing Adverse Effects in Therapeutic Use

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov